{"id":"W4408549696","doi":"10.1111/cas.16459","title":"Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration‐Resistant Prostate Cancer: <scp>PROpel</scp> Subset Analysis","year":2025,"lang":"en","type":"article","venue":"Cancer Science","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Placebo; Clinical endpoint; Hazard ratio; Prostate cancer; Internal medicine; Population; Abiraterone; Oncology; Confidence interval; Abiraterone acetate; Urology; Cancer; Clinical trial; Androgen deprivation therapy; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002389907,0.0007930751,0.001662797,0.0003556961,0.0002490026,0.000817303,0.0004277529,0.0002444364,0.00195983],"category_scores_gemma":[0.0008626435,0.0002638112,0.002752847,0.0006472039,0.0002969911,0.0004300915,0.0004324109,0.000915155,0.0003836506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000431676,"about_ca_system_score_gemma":0.001301855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001114244,"about_ca_topic_score_gemma":0.004314425,"domain_scores_codex":[0.9995042,0.0002649712,0.00004809495,0.00005859855,0.00006550932,0.00005858061],"domain_scores_gemma":[0.9993584,0.0001220339,0.0001823898,0.0001015278,0.00008400461,0.0001516522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6997566,0.003584093,0.1031439,0.001526651,0.01366092,0.000575269,0.000391962,0.003041342,0.02410368,0.0003093094,0.005171901,0.1447344],"study_design_scores_gemma":[0.2799253,0.2215444,0.3997619,0.000421435,0.04567441,0.004569745,0.00117512,0.009628066,0.01574834,0.001775591,0.01956359,0.0002120983],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941369,0.001810837,0.0004098259,0.000160637,0.00003852318,0.0003567247,0.001891989,0.00003998949,0.001154537],"genre_scores_gemma":[0.9928291,0.001170351,0.001046379,0.0003390432,0.00007477589,0.00048109,0.003312512,0.00001974669,0.0007269462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002389907,"threshold_uncertainty_score":0.01263916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01769336179378932,"score_gpt":0.3220274687171265,"score_spread":0.3043341069233371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}